Madison, WI, United States of America

Mitch James Biermann

This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mitch James Biermann: Innovator in Cardiac Cell Development

Introduction

Mitch James Biermann is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of regenerative medicine, particularly in the development of cardiomyocytes from human pluripotent cells. His innovative approach has the potential to advance cardiac research and therapies.

Latest Patents

Mitch holds a patent titled "Method of making cardiomyocytes from human pluripotent cells." This patent presents an improvement to the GiWi protocol for differentiating human pluripotent cells into developmentally mature cardiomyocytes. The method includes a crucial step of activating innate immunity in mesoderm stage cells during the in vitro differentiation culture. By priming mesoderm cells with an innate immunity activator, the resulting population of cardiomyocytes is more developmentally mature compared to those generated without this priming step. Additionally, the patent describes in vitro ventricular conductive microtissues and isolated populations of ventricular conduction system-like cells, along with methods for their creation.

Career Highlights

Mitch is associated with the Wisconsin Alumni Research Foundation, where he continues to explore innovative solutions in cardiac cell development. His work is instrumental in bridging the gap between basic research and clinical applications.

Collaborations

Mitch collaborates with Timothy Joseph Kamp, a fellow researcher in the field. Their partnership enhances the research efforts aimed at improving cardiac cell therapies.

Conclusion

Mitch James Biermann's contributions to the field of regenerative medicine, particularly through his patent on cardiomyocyte development, highlight his role as an innovator. His work has the potential to significantly impact cardiac research and treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…